Atlas Trials

Anthrax-rPA: Safety, Tolerability, Immunogenicity

Clinical trial NCT00063843 · COMPLETED

Trial details

NCT number
NCT00063843
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Anthrax
Start date
2003-07-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.